tiprankstipranks
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market
MRVL
Marvel Biosciences Corp
RESEARCH TOOLSreports

Marvel Biosciences Corp (MRVL) Financial Statements

41 Followers

Marvel Biosciences Corp Financial Overview

Marvel Biosciences Corp's market cap is currently C$8.12M. The company's EPS TTM is C$-0.005; its P/E ratio is -6.62; Marvel Biosciences Corp is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 25Oct 24Oct 23Oct 22Jul 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -547.37KC$ 0.00C$ -887.52KC$ -1.38MC$ -613.10K
Operating IncomeC$ -1.25MC$ -1.22KC$ -2.32MC$ -2.54MC$ 806.33K
EBITDAC$ -1.94MC$ -1.54MC$ -2.25MC$ -2.55MC$ -1.25M
Net IncomeC$ -2.21MC$ -1.65KC$ -2.29MC$ -2.55MC$ -3.04M
Balance Sheet
Cash & Short-Term InvestmentsC$ 128.85KC$ 345.77KC$ 556.62KC$ 593.21KC$ 2.39M
Total AssetsC$ 326.71KC$ 491.31KC$ 672.39KC$ 913.54KC$ 2.47M
Total DebtC$ 2.31MC$ 1.71MC$ 1.00MC$ 0.00C$ 0.00
Net DebtC$ 2.18MC$ 1.36MC$ 443.38KC$ -593.21KC$ -2.39M
Total LiabilitiesC$ 4.33MC$ 3.32MC$ 2.39MC$ 718.00KC$ 112.48K
Stockholders' EquityC$ -4.01MC$ -2.83MC$ -1.72MC$ 195.54KC$ 2.36M
Cash Flow
Free Cash FlowC$ -1.15MC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37M
Operating Cash FlowC$ -1.15MC$ -1.18MC$ -1.33MC$ -2.19MC$ -1.37M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 381.57K
Financing Cash FlowC$ 933.41KC$ 968.64KC$ 1.30MC$ 394.00KC$ 3.16M
Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

Income Statement >

Marvel Biosciences Corp Debt to Assets

Balance Sheet >

Marvel Biosciences Corp Cash Flow

Cash Flow >

Marvel Biosciences Corp Forecast EPS vs Actual EPS

Earnings >